FYN and cancer: To investigate this further, we assessed whether simultaneous inhibition of FYN by PP2, which selectively targets the SRC family kinase inhibitor with the highest potency against FYN, in combination with other kinase inhibitors (TKIs), could inhibit cancer cell growth (Hanke et al., 1996).